The comparative effectiveness of ondansetron and granisetron in a once daily dosage in the prevention of nausea and vomiting caused by cisplatin: A double-blind clinical trial

Pharmaceutical Journal

Volumn 265, Issue 7104, 2000, Pages 59-62

  Stewart, Linda ^a   Crawford, S M ^b   Taylor, P A ^b  

^a AIREDALE GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; GRANISETRON; ONDANSETRON;

ADULT; AGED; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENCY; HUMAN; NAUSEA; RANDOMIZED CONTROLLED TRIAL; VOMITING;

EID: 0034622378     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Jones AL, Cunningham D. Management of vomiting associated with cytotoxic therapy. Br J Hosp Med 1991;45:85-8.
2. Del Favero A, Roila F, Tonato M. Reducing chemotherapy induced nausea and vomiting. Drug Safety 1993;9:410-28.
3. 3 receptor antagonists the same? Eur J Cancer 1992;28A(Suppl 1):2-6.
4. Italian Group for Antiemetic Research. Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin induced emesis. Ann Oncol 1995;6:805-10.
5. 3 receptor antagonists, an overview of their present status and future potential in cancer therapy induced emesis. Drugs 1991;42:551-68.
6. Smyth JF, Coleman RE, Nicolson M, Gallmeier WM, Leonard RCF, Cornbleet MA et al. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? BMJ 1991;303:1423-6.
7. Corticosteroids and lorazepam as antiemetics in cancer chemotherapy. Drug Ther Bull 1986;24:46-8.
8. McMurray A, Steward WP. Treatment of vomiting induced by cytotoxic agents. Prescribers J 1992;32:177-84.
9. Tsavaris N, Fountzilas G, Mylonakis N, Athanassiadis A, Komas C, Karakousis C et al. A randomized comparative study of antiemetic prophylaxis with ondansetron in a single 32mg loading dose versus 8mg every 6 hours in patients undergoing cisplatin based chemotherapy. Oncology 1998;55:513-6.
10. Krzakowski M, Graham E, Goedhals L, Joly F, Pawlicki M, Rapoport B et al. A multicentre, double blind comparison of IV and oral administration of ondansetron plus dexamethasone for acute cisplatin induced emesis. Ondansetron Acute Emesis Study Group. Anticancer Drugs. 1998;9:593-8.
11. Italian Group for Antiemetic Research. Double blind dose finding study of four intravenous doses of dexamethasone in the prevention of cisplatin induced acute emesis. J Clin Oncol 1998;16:2937-42.
12. Goedhals L, Heron JF, Kleisbauer JP, Pagani O, Sessa C. Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: a double blind, placebo controlled, comparative study. Ann Oncol 1998;9:661-6.
13. Sorbe BG, Beglind AM, Andersson H, Boman K, Hoberg T, Hallgren M et al. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum induced nausea and emesis. Cancer 1998;83:1022-32.
14. Italian Group for Antiemetic Research. Cisplatin induced delayed emesis: Pattern and prognostic factors during three subsequent cycles. Ann Oncol 1994;5:585-9.
15. Merrifield KR, Chaffee BJ. (1989) Therapy review, recent advances in the management of nausea and vomiting caused by antineoplastic agents. Clin Pharm 1989;8:187-99.
16. Ondansetron to prevent chemotherapy induced vomiting. Drug Ther Bull 1992;30:21-3.
17. Tzekova VI, Velikova MT, Koynov KD. Granisetron in repeated cycles of chemotherapy with platinum. Neoplasma 1998;45:1.
18. de Wit R, van den Berg H, Burghouts J, Nortier J, Slee P, Rodenberg C et al. Initial high anitemetic efficacy of granisetron with dexamethasone is not maintained over repeated cycles. BrJ Cancer 1998;77:1487-91.